RS
Randhir Singh Guleria
About Randhir Singh Guleria
Data last updated:
Randhir Singh Guleria is a Director at Asepta Biosystems Private Limited (since 2018) and Director at Biodigm Private Limited (since 2025). The companies operate in Electrnoics. The largest current company by reported revenue is Asepta Biosystems Private Limited at ₹12.1 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Asepta Biosystems Private Limited U29308PB2017PTC046834 | Director | 01 May 2018 | 2017 | ₹12.1 Lakh (FY 2020) | Active |
 Biodigm Private Limited U21000PB2025PTC064105 | Director | 04 Apr 2025 | 2025 | Active |
Board colleagues of Randhir Singh Guleria
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Kumar Banga | 07853853 | Asepta Biosystems Private Limited , Biodigm Private Limited | Director |
| Gurmukh Singh | 07853851 | Asepta Biosystems Private Limited | Director |
| Karthikeyan Manickavasagan | 03087590 | Asepta Biosystems Private Limited | Director |
| Dharmendra Kumar Srivastava | 03360426 | Biodigm Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Randhir Singh Guleria
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Randhir Singh Guleria
Randhir Singh Guleria currently holds 2 directorships: Asepta Biosystems Private Limited (Director, since 01 May 2018, revenue ₹12.1 Lakh (FY 2020)); Biodigm Private Limited (Director, since 04 Apr 2025).
Randhir Singh Guleria was first appointed on 01 May 2018 as Director at Asepta Biosystems Private Limited. The most recent appointment on record is 04 Apr 2025 at Biodigm Private Limited.
The current boards of Randhir Singh Guleria's companies include Ajay Kumar Banga (Asepta Biosystems Private Limited), Gurmukh Singh (Asepta Biosystems Private Limited), Karthikeyan Manickavasagan (Asepta Biosystems Private Limited), Dharmendra Kumar Srivastava (Biodigm Private Limited).